95 -11 (49) 2022 — Zhumaev M.Yu., Zhumaeva N.M. — ASSESSMENT OF QUALITY OF LIFE IN PATIENTS WITH MALIGNANT PLEURAL EFFUSION

ASSESSMENT OF QUALITY OF LIFE IN PATIENTS WITH MALIGNANT PLEURAL EFFUSION

Zhumaev M.Yu., Termez branch of the Tashkent Medical Academy

Zhumaeva N.M. Termez branch of the Tashkent Medical Academy

Resume

As a result of the study, the authors made no conclusions: The detection of malignant pleural effusion is an absolute indication for active treatment using surgical methods and induction of pleurodesis. And the method of treatment is chosen individually, however, the method of choice is thoracoscopy in the early stages of the disease with the induction of pleurodesis by surgical methods: pleurectomy, argon-plasma coagulation of the pleura.

Key words: quality of life assessment, malignant lung disease, pleural effusion, pleurodesis induction, pleurectomy, argon plasma coagulation of the pleura.

First page

539

Last page

541

For citation: Zhumaev M.Yu., Zhumaeva N.M. – ASSESSMENT OF QUALITY OF LIFE IN PATIENTS WITH MALIGNANT PLEURAL EFFUSION //New Day in Medicine 11(49)2022 539-541 https://clck.ru/32tUwh

LIST OF REFERENCES:

1. Карлсон Арулдас Современные возможности улучшения диагностики и лечения рецидивирующих плевральных выпотов: дис. …канд. мед. наук: 14.01.17. / Карлсон Арулдас. – СПб., 2018. – 105 с.
2. Клименко В.Н. Опухолевые плевриты: современный взгляд на проблему / В.Н. Клименко, О.В. Иванов // Вестник хирургии им. И.И. Грекова. – 2014. – №2. – С. 114-117.
3. Маскелл Н.А., Бутланд Р.Дж.А. Рекомендации Британского Торакального общества (BTS) по обследованию взрослых больных с односторонним плевральным выпотом //Пульмонология. 2006. № 2. С. 13–26.
4. Amin Z., Iskandar S.D. Sibli Prognostic Factors of 30-day Survival of Patients with Malignant Pleural Effusion. //Indian J. Palliat Care. 2017;23:321–324.
5. Fitzgerald D.B., Koegelenberg C.FN., Yasufuku K. et al. Expert Review of Respiratory Medicine Surgical and non-surgical management of malignant pleural effusions. //Expert Rev Respir Med 2018; 12: 15–26.
6. Mishra E., Corcoran J., Hallifax R. et al. Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions. //PLoS One 2015; 10: e0123798.
7. O’Leary B.D., Treacy T., Geoghegan T., Walsh T.A., Boyd W.D., Brennan D.J. Incidental Thoracic Findings on Routine Computed Tomography in Epithelial Ovarian Cancer. //Int. J. Gynecol. Cancer. 2018;28:1073–1076.
8. Porcel J.M., Solé C., Salud A., Bielsa S. Prognosis of Cancer with Synchronous or Metachronous Malignant Pleural Effusion. //Lung. 2017; 195:775–779.
9. Sahn S.A., Huggins J.T., San Jose E., Alvarez-Dobano J.M., Valdes L. The Art of Pleural Fluid Analysis. //Clin. Pulm. Med. 2013; 20:77–96.